Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON32338Active, not recruiting
Open-label, single-arm trial of rocuronium, sponsored by University Medical Center Groningen. Primary endpoint: Prediction accuracy of PK-PD-potentiation model. Started Apr 2009; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON32338.